SCHEMBL8083294

SCHEMBL8083294

C=C(C)C(=O)CNC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
CA12 O43570 7/20 0.39
CA2 P00918 7/20 0.39
CA1 P00915 6/20 0.39
CA9 Q16790 6/20 0.39
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
CA14 Q9ULX7 1/20 0.38
APLNR P35414 1/20 0.38
EPHX2 P34913 1/20 0.37
EPHX1 P07099 1/20 0.37
KDM4A O75164 1/20 0.37
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131272 0.84 TDP1 (0.47) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL18689367 0.82 TDP1 (0.48) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL19752818 0.80 MEN1 (0.42) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL13019150 0.80 MEN1 (0.49) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL14044868 0.80 MEN1 (0.49) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL27429142 0.79 TDP1 (0.50) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL959018 0.79 TDP1 (0.50) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL8295860 0.78 MAOA (0.51) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL18902256 0.78 TDP1 (0.46) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL22416651 0.78 TDP1 (0.46) TDP1MAOAMAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512851-B1 BETA-LACTAMASE INHIBITOR COMPOUNDS ENTASIS THERAPEUTICS LTD (GB) 2022-07-06 EP disclosed
EP-2834239-B1 HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS ENTASIS THERAPEUTICS LTD (GB) 2017-12-27 EP disclosed
WO-2009045497-A1 CRYSTALLINE PEPTIDE EPOXY KETONE PROTEASE INHIBITORS AND THE SYNTHESIS OF AMINO ACID KETO-EPOXIDES PROTEOLIX, INC. (US) 2009-04-09 WO disclosed